Does universal active MRSA surveillance influence anti-MRSA antibiotic use? A retrospective analysis of the treatment of patients admitted with suspicion of infection at Veterans Affairs Medical Centers between 2005 and 2010
Makoto Jones(Centers for Disease Control and Prevention), Matthew H. Samore(University of Utah), Michael Rubin(Boston Medical Center), Matthew Bidwell Goetz(University of California, Los Angeles), Angela Huttner(University Hospital of Geneva), William R. Tanner(University of Utah), Karl Madaras‐Kelly(Idaho State University), K. Damal(University of Utah), Molly Leecaster(University of Utah), Christopher Nielson(University of Nevada, Reno), Benedikt Huttner(World Health Organization)
Cited by 11
Related Papers
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
|Clinical Infectious Diseases|2016|3k
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
|The Lancet Infectious Diseases|2025|526
Effects of Protease Inhibitors on Hyperglycemia, Hyperlipidemia, and Lipodystrophy
|Archives of Internal Medicine|2000|457
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
|Antimicrobial Resistance and Infection Control|2013|454